$MANH
MANHATTAN ASSOCIATES INC

2024 Q4 Form 10-Q Financial Statement

#000095017024117433 Filed on October 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $266.7M
YoY Change 11.84%
Cost Of Revenue $118.7M
YoY Change 6.48%
Gross Profit $148.0M
YoY Change 16.55%
Gross Profit Margin 55.5%
Selling, General & Admin $36.89M
YoY Change -5.45%
% of Gross Profit 24.92%
Research & Development $34.35M
YoY Change 3.8%
% of Gross Profit 23.21%
Depreciation & Amortization $1.688M
YoY Change 20.57%
% of Gross Profit 1.14%
Operating Expenses $72.93M
YoY Change 1.13%
Operating Profit $75.09M
YoY Change 40.49%
Interest Expense $300.0K
YoY Change -175.0%
% of Operating Profit 0.4%
Other Income/Expense, Net $1.312M
YoY Change -24.55%
Pretax Income $76.40M
YoY Change 38.44%
Income Tax $12.62M
% Of Pretax Income 16.52%
Net Earnings $63.78M
YoY Change 29.06%
Net Earnings / Revenue 23.92%
Basic Earnings Per Share $1.04
Diluted Earnings Per Share $1.03
COMMON SHARES
Basic Shares Outstanding 61.08M 61.25M
Diluted Shares Outstanding 61.95M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $215.0M
YoY Change 17.91%
Cash & Equivalents $215.0M
Short-Term Investments
Other Short-Term Assets $37.61M
YoY Change 38.25%
Inventory
Prepaid Expenses
Receivables $199.8M
Other Receivables $0.00
Total Short-Term Assets $452.3M
YoY Change 15.13%
LONG-TERM ASSETS
Property, Plant & Equipment $62.90M
YoY Change 458.34%
Goodwill $62.24M
YoY Change 0.01%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $120.7M
YoY Change 287.53%
Total Long-Term Assets $245.8M
YoY Change 36.47%
TOTAL ASSETS
Total Short-Term Assets $452.3M
Total Long-Term Assets $245.8M
Total Assets $698.1M
YoY Change 21.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.18M
YoY Change -8.2%
Accrued Expenses $86.24M
YoY Change -7.87%
Deferred Revenue $252.5M
YoY Change 18.32%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $362.2M
YoY Change 8.84%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $57.95M
YoY Change 319.08%
Total Long-Term Liabilities $57.95M
YoY Change 319.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $362.2M
Total Long-Term Liabilities $57.95M
Total Liabilities $420.2M
YoY Change 21.21%
SHAREHOLDERS EQUITY
Retained Earnings $303.4M
YoY Change 27.29%
Common Stock $610.0K
YoY Change -0.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $278.0M
YoY Change
Total Liabilities & Shareholders Equity $698.1M
YoY Change 21.84%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $63.78M
YoY Change 29.06%
Depreciation, Depletion And Amortization $1.688M
YoY Change 20.57%
Cash From Operating Activities $62.30M
YoY Change 6.31%
INVESTING ACTIVITIES
Capital Expenditures $1.009M
YoY Change -8.27%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.009M
YoY Change -8.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -51.60M
YoY Change 94.0%
NET CHANGE
Cash From Operating Activities 62.30M
Cash From Investing Activities -1.009M
Cash From Financing Activities -51.60M
Net Change In Cash 9.686M
YoY Change -68.65%
FREE CASH FLOW
Cash From Operating Activities $62.30M
Capital Expenditures $1.009M
Free Cash Flow $61.29M
YoY Change 6.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001056696
CY2024Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2023Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-23999
dei Entity Registrant Name
EntityRegistrantName
MANHATTAN ASSOCIATES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
GA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
58-2373424
dei Entity Address Address Line1
EntityAddressAddressLine1
2300 Windy Ridge Parkway
dei Entity Address Address Line2
EntityAddressAddressLine2
Tenth Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30339
dei City Area Code
CityAreaCode
770
dei Local Phone Number
LocalPhoneNumber
955-7070
dei Security12b Title
Security12bTitle
Common stock
dei Trading Symbol
TradingSymbol
MANH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61075279
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
214952000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
270741000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
199756000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
181173000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
37605000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27276000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
452313000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
479190000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12809000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11795000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
50094000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21645000
CY2024Q3 us-gaap Goodwill
Goodwill
62236000
CY2023Q4 us-gaap Goodwill
Goodwill
62235000
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
86551000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
66043000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
34137000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
32445000
CY2024Q3 us-gaap Assets
Assets
698140000
CY2023Q4 us-gaap Assets
Assets
673353000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
23183000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
24508000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
63010000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
73210000
CY2024Q3 manh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
23227000
CY2023Q4 manh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
27374000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
252537000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
237793000
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
286000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3030000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
362243000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
365915000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50028000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17694000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7918000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11466000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61072619
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61072619
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61566037
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61566037
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
610000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
615000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
303361000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
304701000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-26020000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-27038000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
277951000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
278278000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
698140000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
673353000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
266681000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238441000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
786551000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
690470000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34349000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33093000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
104693000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
95487000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16586000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17650000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
55669000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
54278000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20308000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21371000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
62623000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61561000
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1688000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1440000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4670000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4247000
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
191591000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
184993000
us-gaap Costs And Expenses
CostsAndExpenses
585643000
us-gaap Costs And Expenses
CostsAndExpenses
539454000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
75090000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
53448000
us-gaap Operating Income Loss
OperatingIncomeLoss
200908000
us-gaap Operating Income Loss
OperatingIncomeLoss
151016000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1312000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1739000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3222000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2923000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
76402000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
55187000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
204130000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
153939000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12621000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5766000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33782000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26107000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
63781000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
49421000
us-gaap Net Income Loss
NetIncomeLoss
170348000
us-gaap Net Income Loss
NetIncomeLoss
127832000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.8
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.77
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.07
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.05
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61169000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61639000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61404000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61902000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61948000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62310000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62186000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62501000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
63781000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
49421000
us-gaap Net Income Loss
NetIncomeLoss
170348000
us-gaap Net Income Loss
NetIncomeLoss
127832000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1734000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2086000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1018000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1294000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
65515000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
47335000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
171366000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
126538000
us-gaap Profit Loss
ProfitLoss
170348000
us-gaap Profit Loss
ProfitLoss
127832000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4670000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4247000
us-gaap Share Based Compensation
ShareBasedCompensation
70614000
us-gaap Share Based Compensation
ShareBasedCompensation
53598000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
131000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-42000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-20544000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-18359000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-906000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-922000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17515000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17168000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
9688000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
7747000
manh Increase Decrease In Accounts Payable And Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLiabilities
-13367000
manh Increase Decrease In Accounts Payable And Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLiabilities
13477000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-7956000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-4347000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
12962000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
5362000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
190299000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
157859000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5547000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2761000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5547000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2761000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
241150000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
195716000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-241150000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-195716000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
609000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2533000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-55789000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-43151000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
270741000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
225463000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
214952000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
182312000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
240629000
CY2024Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
51604000
CY2024Q3 manh Excise Tax On Net Stock Repurchases
ExciseTaxOnNetStockRepurchases
442000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
23853000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1734000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
63781000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
277951000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
278278000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
241150000
manh Excise Tax On Net Stock Repurchases
ExciseTaxOnNetStockRepurchases
1157000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
70614000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1018000
us-gaap Net Income Loss
NetIncomeLoss
170348000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
277951000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
170550000
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
26601000
CY2023Q3 manh Excise Tax On Net Stock Repurchases
ExciseTaxOnNetStockRepurchases
209000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
19030000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2086000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
49421000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
210105000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
226800000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
195716000
manh Excise Tax On Net Stock Repurchases
ExciseTaxOnNetStockRepurchases
1115000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
53598000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1294000
us-gaap Net Income Loss
NetIncomeLoss
127832000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
210105000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1700000000
us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
We expect to recognize revenue on approximately 40% of these remaining performance obligations over the next 24 months with the majority of the remaining balance recognized over the following 36 months.
manh Expected Percentage Of Revenue Recognized From Remaining Performance Obligation Over Twenty Four Months
ExpectedPercentageOfRevenueRecognizedFromRemainingPerformanceObligationOverTwentyFourMonths
0.40
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P24M
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
900000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
900000
CY2024Q3 manh Other Provisions For Doubtful Accounts Valuation Allowance
OtherProvisionsForDoubtfulAccountsValuationAllowance
3200000
CY2023Q4 manh Other Provisions For Doubtful Accounts Valuation Allowance
OtherProvisionsForDoubtfulAccountsValuationAllowance
4400000
us-gaap Revenue Practical Expedient Remaining Performance Obligation Description
RevenuePracticalExpedientRemainingPerformanceObligationDescription
We apply the practical expedient to expense sales commissions when the amortization period would have been one year or less.
CY2024Q3 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
2600000
CY2023Q3 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
2400000
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
7900000
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
7000000
us-gaap Deferred Sales Inducement Cost Impairment Loss
DeferredSalesInducementCostImpairmentLoss
0
us-gaap Deferred Sales Inducement Cost Impairment Loss
DeferredSalesInducementCostImpairmentLoss
0
CY2024Q3 us-gaap Cash
Cash
102400000
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
112600000
CY2024Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
23900000
CY2023Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
19000000
us-gaap Restricted Stock Expense
RestrictedStockExpense
70600000
us-gaap Restricted Stock Expense
RestrictedStockExpense
53600000
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.165
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.104
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.165
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.17
CY2024Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-3000000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
63781000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
49421000
us-gaap Net Income Loss
NetIncomeLoss
170348000
us-gaap Net Income Loss
NetIncomeLoss
127832000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.8
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.77
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.07
CY2024Q3 manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.01
CY2023Q3 manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.01
manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.03
manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.02
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.05
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61169000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61639000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61404000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61902000
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
779000
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
671000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
782000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
599000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61948000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62310000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62186000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62501000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
266681000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238441000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
118660000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
111439000
CY2024Q3 manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
71243000
CY2023Q3 manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
72114000
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1688000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1440000
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
191591000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
184993000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
75090000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
53448000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
786551000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
690470000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
357988000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
323881000
manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
222985000
manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
211326000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4670000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4247000
us-gaap Costs And Expenses
CostsAndExpenses
585643000
us-gaap Costs And Expenses
CostsAndExpenses
539454000
us-gaap Operating Income Loss
OperatingIncomeLoss
200908000
us-gaap Operating Income Loss
OperatingIncomeLoss
151016000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-117433-index-headers.html Edgar Link pending
0000950170-24-117433-index.html Edgar Link pending
0000950170-24-117433.txt Edgar Link pending
0000950170-24-117433-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
manh-20240930.htm Edgar Link pending
manh-20240930.xsd Edgar Link pending
manh-ex31_1.htm Edgar Link pending
manh-ex31_2.htm Edgar Link pending
manh-ex32.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
manh-20240930_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending